Davis Todd C

Average Profitability
24.73%
Insider Buys Quantity
3
Insider Buys Sum
$644,509.30
Insider Sells Quantity
8
Insider Sells Sum
$6.2M

Insider Activity of Davis Todd C

According to the SEC Form 4 filings, Davis Todd C, being in a position of

  1. Chief Executive Officer at Ligand Pharmaceuticals Incorporated,
    оver the last 12 months, has bought 2500 shares for $243,481, and sold 0 shares,
    over all time since 2011-08-10, has bought 21500 shares for $644,509, and sold 36170 shares for $6.01M.

The largest purchase of all time was on 2024-08-08 and amounted to 2500 shares of Ligand Pharmaceuticals Incorporated for $243,481.

The largest sale of all time was on 2018-02-27 and amounted to 12335 shares of Ligand Pharmaceuticals Incorporated for $1.87M.

Biography of Davis Todd C

No biography is available at this moment.

2024-08-08PurchaseLigand Pharmaceuticals Incorporated
LGND
Chief Executive Officer
2,500
0.014%
$97.39$243,481+6.66%
2023-09-22PurchaseLigand Pharmaceuticals Incorporated
LGND
CHIEF EXECUTIVE OFFICER
4,000
0.0232%
$59.38$237,529+24.41%
2020-04-28SaleVaxart, Inc.
VXRT
director
60,000
0.0805%
$3.27$196,500+105.5%
2018-10-08SaleLigand Pharmaceuticals Incorporated
LGND
director
2,500
0.0122%
$253.99$634,978-52.26%
2018-08-17SaleLigand Pharmaceuticals Incorporated
LGND
director
3,167
0.0145%
$239.50$758,497-49.81%
2018-08-16SaleLigand Pharmaceuticals Incorporated
LGND
director
5,833
0.0276%
$239.93$1.4M-48%
2018-02-27SaleLigand Pharmaceuticals Incorporated
LGND
director
12,335
0.0584%
$151.90$1.87M+13.07%
2018-02-26SaleLigand Pharmaceuticals Incorporated
LGND
director
4,835
0.0229%
$153.58$742,536+12.17%
2014-03-19SaleLigand Pharmaceuticals Incorporated
LGND
director
5,000
0.0249%
$79.63$398,147-28.77%
2014-03-18SaleLigand Pharmaceuticals Incorporated
LGND
director
2,500
0.0121%
$79.45$198,637-30.48%
2011-08-10PurchaseLigand Pharmaceuticals Incorporated
LGND
director
15,000
0.0745%
$10.90$163,500+24.73%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.